Answers are grounded in this paper and cite their sources.
SUMMARY Cost and cost‐effectiveness analyses have sometimes been regarded as inappropriate endeavors for a physician dedicated to the welfare of patients. While cost considerations alone should not be used as the decision‐making criterion in managing individual patients, the transfusion medicine physician nevertheless needs to appreciate the value of these analyses when making policy decisions for his or her laboratory and hospital. This article highlights the practical applications of decision analyses as decision‐making tools and recommends that they be regarded as useful adjuncts in the practice of transfusion medicine.
No takes yet. Share an insight, caveat, or question.
Adeyi et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: